Tiphanie Vogel, MD, PhD

Texas Children’s Hospital

Disclosure(s): AstraZeneca: Grant/Research Support; Moderna: Advisor/Consultant; Pfizer: Advisor/Consultant; SOBI: Advisor/Consultant, Board Member; Takeda: Honoraria

Poster(s):

• (P-1651) Long-term Outcomes Compared between Children Hospitalized for Multisystem Inflammatory Syndrome in Children (MIS-C) and Children Hospitalized for Acute COVID-19, New Vaccine Surveillance Network (NVSN) — United States, 2020-2022
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET